SMIRNOFF has announced a new extension of its “Equalizing Music” global campaign through a new partnership with Spotify that promotes equality for women musicians around the world.
According to Spotify data, none of the top 10 most-streamed tracks were performed by women artists or bands in 2017. To help make a difference in the music industry, the makers of SMIRNOFF have teamed up with Spotify to increase representation of women in music by allowing consumers to impact their own listening habits through an industry-first application programming interface (API), dubbed the Smirnoff Equalizer.
To view the multimedia release go to:
https://www.multivu.com/players/English/8279551-smirnoff-equalizer-spotify-music-womens-day/
Today, the American Federation of Government Employees released a microsite site to raise awareness of the threat of privatizing the VA, and the negative impact it will have on veterans.
The site, The Fight Against VA Privatization, can be accessed at www.afge.org/VACall and offers viewers reports, data, photos, footage, and information about the largest health care system in the country tailored to the unique needs of our nation’s veterans.
To view the multimedia release go to:
https://www.multivu.com/players/English/8199531-afge-staff-the-va/
The Leukemia & Lymphoma Society (LLS), the world’s leading voluntary non-profit dedicated to blood cancers, released 30 “proof points” - one for each day of September, Blood Cancer Awareness Month - to demonstrate its impact on the cancer landscape and progress towards a world without blood cancers.
LLS has invested more than $1 billion in research to advance breakthrough therapies and cures for blood cancer patients. In many cases, those treatments are now helping patients with other cancers and chronic diseases. Due to its focus on blood cancers, survival rates are improving. Since the early 1960s, five-year survival rates for many blood cancer patients have doubled, tripled and even quadrupled.
To view the multimedia release go to:
http://www.multivu.com/players/English/7554851-lls-blood-cancer-awareness-month/
International research led by University College London (UCL) as part of the ‘Cities Changing Diabetes’ partnership programme challenges current scientific understanding of the rapid rise of diabetes in cities. The findings suggest that in cities around the world, social and cultural factors play a far more important role in the spread of the epidemic than previously thought.
More than two thirds of the world’s 400 million people with diabetes live in urban areas.1,2 The year-long study for Cities Changing Diabetes, a unique public-private-academic partnership, sought to better understand what makes people vulnerable to type 2 diabetes in cities in order to inform solutions for one of the most pressing modern-day public health challenges. To explore this complex issue, more than 550 interviews were undertaken with at-risk and diagnosed people in five major cities – Copenhagen, Houston, Mexico City, Shanghai and Tianjin.
“By largely focusing on biomedical risk factors for diabetes, traditional research has not adequately accounted for the impact of social and cultural drivers of disease,” says David Napier, Professor of Medical Anthropology, UCL. “Our pioneering research will enable cities worldwide to help populations adapt to lifestyles that make them less vulnerable to diabetes.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7690951-study-rethink-rise-diabetes-in-cities/
The modern cotton industry has achieved significant environmental gains over the past forty years, but it is not resting on its laurels. Around the world, scientists and researchers strive to develop new ways to grow, process and manufacture cotton more efficiently and with increasingly less impact on the environment. Identifying and implementing new technologies and practices will help the cotton industry meet the current needs for productivity and profit, without compromising the ability of future generations to meet their own needs.
Increasingly responsible production and manufacturing are not objectives the cotton industry take lightly. As a natural fiber, the success of cotton is directly linked to the land and its health. Being good stewards of the environment requires continuous attention to reducing impact throughout every link in cotton’s long supply chain—from the seeds from which cotton is grown, to the processing and manufacturing practices of finished cotton goods.
To view the multimedia release go to:
http://www.multivu.com/players/English/7613831-cotton-sustainability/
New data from a school asthma management program, “Building Bridges for Asthma Care,” presented today at the American Thoracic Society 2015 International Conference, show a significant decrease in school absenteeism among children with asthma from inner-city schools who were enrolled in the program. Absences dropped 11.75 percent among children enrolled in Building Bridges, compared to an increase of 8.48 percent in children with asthma not in the program.
“Building Bridges for Asthma Care” is a school-based program designed to empower nurses in participating elementary schools to ensure that asthmatic children are identified and provided care according to the National Institute of Health’s clinical treatment guidelines. The objectives of the program are addressing the risk of health disparities and asthma-related absenteeism, as well as its related impact on academic achievement for inner city students.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7506851-gsk-building-bridges-for-asthma-care/
Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), announced today that its first doses of the Fluzone® (Influenza Vaccine) portfolio for the 2017-2018 influenza (“flu”) season have been released by the U.S. Food and Drug Administration (FDA). Sanofi Pasteur has begun distributing initial shipments, representing the first of nearly 70 million total doses of seasonal influenza vaccine manufactured by the company for this upcoming influenza season. Widespread shipment of Fluzone Quadrivalent, Fluzone High-Dose and Fluzone Intradermal Quadrivalent vaccine to health care provider offices, pharmacies and other immunizers will begin in early August to support fall immunization campaigns.
“As we enter the Swiftwater site’s 120th year, it reminds us of our innovation and growth as we came to understand the science of influenza and its impact on human health,” said David P. Greenberg, M.D., Associate Vice President and Regional Medical Head North America, Sanofi Pasteur. “Influenza can be especially severe for the most vulnerable populations, including the elderly, young children and those with compromised immune systems; however, it can also have a serious health impact on otherwise healthy individuals. Sanofi Pasteur is and always has been deeply committed to improving public health by continuously striving to develop new vaccines and on improving existing ones.”
To view the multimedia release go to:
https://www.multivu.com/players/English/8081151-sanofi-pasteur-influenza-vaccine-first-shipment-2017/
On World Mental Health Day, Janssen has announced the results of a pan-European research project: ‘Talking About Treatment in Schizophrenia: A Patient and Carer Survey’. The survey of 166 adults living with schizophrenia and 468 carers was conducted by the independent market research agency, Fieldwork International (part of Ipsos MORI), and explored awareness, feelings and preferences regarding treatment.
The survey, conducted across 12 countries in Europe (Austria, Belgium, Denmark, France, Germany, Italy, Netherlands, Russia, Spain, Sweden, Switzerland and the UK), highlighted key factors affecting the peace of mind for carers, such as the impact of the condition on day‑to-day life, potential relapse/hospitalisation and getting support beyond medication. 94% stated they reminded the person they care for to take their medication and for 49% this happens often.
To view the multimedia release go to:
http://www.multivu.com/players/uk/7947151-janssen-survey-carers-adults-schizophrenia/
November is National Alzheimer’s Disease Awareness Month, a time to focus on finding ways to prevent the disease and enrich the lives of millions of Americans who live with, or care for, someone with Alzheimer’s. Brookdale, a leading owner and operator of senior living solutions throughout the United States, has a long-standing commitment to support research to reduce the impact of Alzheimer’s, which is the sixth leading cause of death in the United States.
To view Multimedia News Release, go to http://www.multivu.com/players/English/64011-brookdale-senior-living-alzheimer-awareness/
Promotional Products Work! Week, February 25 through March 1, 2013, sponsored by Promotional Products Association International (PPAI), the world’s largest and oldest international not-for-profit promotional products association founded in 1903, is an industry event dedicated to demonstrating the importance of promotional products as a powerful and effective advertising medium. A new study released by PPAI this week, The Influence of Promotional Products on Consumer Behavior, demonstrates that advertisers and marketers, now more than ever, can look to promotional products to deliver the highest rate of reach, recall and return on investment in the advertising industry, as the most cost-effective way to impact a targeted audience in a tangible, long-lasting and memorable manner.
To view Multimedia News Release, go to http://www.multivu.com/mnr/60314-ppai-celebrates-promotional-products-work-week
Today, WebMD released In Their Own Words: Moving Beyond Migraine with Robin Roberts, a new five-part video series that sheds light on the debilitating nature of migraine and the impact it has on all aspects of a sufferer’s personal and professional life.
To learn more about treatments and the individuals featured in In Their Own Words: Moving Beyond Migraine with Robin Roberts, visit: to www.webmd.com/insidemigraines.
Moving Beyond Migraine follows the lives of Jennifer, a public school administrator who has lived with intense migraine headaches for over 20 years; Kate, a 20-year-old college student with debilitating migraines that have run in her family for generations; Melanie, whose intense migraine condition has altered the dynamics of her nine year marriage; and Lynn, who after suffering from migraine for 50 years, shares how a clinical trial for a new treatment called CGRP targeted therapy is finally providing her with some relief.
To view the multimedia release go to:
https://www.multivu.com/players/English/7579759-robin-roberts-moving-beyond-migraine/